参考文献/References:
[1] El Saghier EO, Shebl SE, Fawzy OA,et al. Androgen deficiency and erectile dysfunction in patients with type 2 diabetes[J].Clin Med Insights Endocrinol Diabetes, 2015,8:55-62. DOI: 10.4137/CMED.S27700.
[2] Rhoden EL, Ribeiro EP, Teloken C,et al. Diabetes mellitus is associated with subnormal serum levels of free testosterone in men[J].BJU Int, 2005,96(6):867-870. DOI:10.1111/j.1464-410X.2005.05728.x.
[3] Daka B, Langer RD, Larsson CA,et al. Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus[J].BMC Endocr Disord, 2015,15:35. DOI: 10.1186/s12902-015-0034-1.
[4] Cheung KK, Luk AO, So WY,et al. Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: a review of current evidence[J].J Diabetes Investig, 2015,6(2):112-123. DOI: 10.1111/jdi.12288.
[5] Nada SE, Thompson RC, Padmanabhan V. Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues[J].Endocrinology, 2010,151(11):5165-5173. DOI: 10.1210/en.2010-0666.
[6] Cunningham GR. Testosterone and metabolic syndrome[J].Asian J Androl, 2015,17(2):192-196. DOI: 10.4103/1008-682X.148068.
[7] Al Hayek AA, Khader YS, Jafal S,et al. Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study[J].J Family Community Med, 2013,20(3):179-186. DOI: 10.4103/2230-8229.122006.
[8] Rao PM, Kelly DM, Jones TH. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men[J].Nat Rev Endocrinol, 2013,9(8):479-493. DOI: 10.1038/nrendo.2013.122.
[9] Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis[J].JAMA, 2006,295(11):1288-1299. DOI:10.1001/jama.295.11.1288.
[10] Aslan Y, Guzel O, Balci M, et al. The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction[J].Aging Male, 2014,17(2):76-80. DOI: 10.3109/13685538.2014.895318.
[11] Kapoor D, Aldred H, Clark S,et al. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity[J].Diabetes Care, 2007,30(4):911-917. DOI:10.2337/dc06-1426.
[12] Basu AK, Singhania P, Bandyopadhyay R,et al. Late onset hypogonadism in type 2 diabetic and nondiabetic male: a comparative study[J].J Indian Med Assoc, 2012,110(8):573-575.
[13] Morton A. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes[J].J Clin Endocrinol Metab, 2005,90(3):1903. DOI:10.1210/jc.2004-2310.
[14] Chandel A, Dhindsa S, Topiwala S, et al. Testosterone concentration in young patients with diabetes[J].Diabetes Care, 2008,31(10):2013-2017. DOI: 10.2337/dc08-0851.
[15] McCabe MJ, Bancalari RE, Dattani MT. Diagnosis and evaluation of hypogonadism[J].Pediatr Endocrinol Rev, 2014,11(Suppl 2):214-229.
[16] Heufelder AE, Saad F, Bunck MC,et al. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone[J].J Androl, 2009,30(6):726-733. DOI: 10.2164/jandrol.108.007005.
[17] El Baba K, Azar ST. Low testosterone and diabetes[J].Curr Diabetes Rev, 2013,9(5):418-421.
[18] Raz I, Eldor R, Cernea S,et al. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage[J].Diabetes Metab Res Rev, 2005,21(1):3-14. DOI:10.1002/dmrr.493.
[19] Bhattacharya RK, Khera M, Blick G,et al. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US(TRiUS)[J].BMC Endocr Disord, 2011,11:18. DOI: 10.1186/1472-6823-11-18.
[20] Thirumalai A, Rubinow KB, Page ST. An update on testosterone, HDL and cardiovascular risk in men[J].Clin Lipidol, 2015,10(3):251-258. DOI:10.2217/clp.15.10.
相似文献/References:
[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(06):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
[11]曹雯,郑仁东,曹琳,等.男性2型糖尿病患者血尿酸与性激素
相关性研究[J].国际内分泌代谢杂志,2016,36(01):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
Cao Wen,Zheng Rendong,Cao Lin,et al.Correlation between blood uric acid and sex hormones in male patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(06):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]